Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro
- PMID: 2857946
- DOI: 10.1016/s0140-6736(85)92144-0
Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro
Abstract
Recombinant human interferon alfa-A (rIFN alpha A) had a dose-related suppressive effect on human T lymphotropic virus type III (HTLV-III) replication in vitro in normal peripheral-blood mononuclear cells (PBMC). Both single-dose and multiple-dose regimens were inhibitory. Such inhibitory concentrations (4-1024 units/ml) were not toxic to PBMC in culture, and were within the ranges achievable in blood after injection. These studies suggest that clinical trials of rIFN alpha A in early HTLV-III infection are warranted.
Similar articles
-
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.J Interferon Res. 1986 Apr;6(2):143-52. doi: 10.1089/jir.1986.6.143. J Interferon Res. 1986. PMID: 2425014
-
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.Lancet. 1985 Jun 29;1(8444):1480-2. doi: 10.1016/s0140-6736(85)92255-x. Lancet. 1985. PMID: 2409414
-
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.Antimicrob Agents Chemother. 1986 Jul;30(1):189-91. doi: 10.1128/AAC.30.1.189. Antimicrob Agents Chemother. 1986. PMID: 3019235 Free PMC article.
-
Prospects of therapy for infections with human T-lymphotropic virus type III.Ann Intern Med. 1985 Nov;103(5):750-5. doi: 10.7326/0003-4819-103-5-750. Ann Intern Med. 1985. PMID: 2413793 Review.
-
Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.Cancer Res. 1985 Sep;45(9 Suppl):4677s-4684s. Cancer Res. 1985. PMID: 2410112 Review.
Cited by
-
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096-100. doi: 10.1073/pnas.82.20.7096. Proc Natl Acad Sci U S A. 1985. PMID: 2413459 Free PMC article.
-
AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):395-402. doi: 10.1016/j.cytogfr.2007.06.005. Epub 2007 Jul 25. Cytokine Growth Factor Rev. 2007. PMID: 17656146 Free PMC article. Review.
-
The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.J Virol. 2017 Mar 13;91(7):e02254-16. doi: 10.1128/JVI.02254-16. Print 2017 Apr 1. J Virol. 2017. PMID: 28100611 Free PMC article.
-
Minimally Modified HIV-1 Infection of Macaques: Development, Utility, and Limitations of Current Models.Viruses. 2024 Oct 16;16(10):1618. doi: 10.3390/v16101618. Viruses. 2024. PMID: 39459950 Free PMC article. Review.
-
Kaposi's sarcoma in AIDS patients: long-term treatment with recombinant interferon alpha-2a and chemotherapy.Klin Wochenschr. 1988 May 16;66(10):437-42. doi: 10.1007/BF01745513. Klin Wochenschr. 1988. PMID: 3135432
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources